切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2013, Vol. 09 ›› Issue (04) : 468 -472. doi: 10.3877/cma.j.issn.1673-5250.2013.04.009

所属专题: 文献

论著

巨大儿的发生及其影响因素
陈蔚1, 武明辉1,*,*(), 张娣1, 侯东敏1, 王军华1, 蒋京伟1, 贾朝霞1   
  1. 1. 100026 北京,首都医科大学附属北京妇产医院 北京妇幼保健院
  • 收稿日期:2013-01-20 修回日期:2013-06-18 出版日期:2013-08-01
  • 通信作者: 武明辉

Occurrence and Influencing Factors of Macrosomia

Wei CHEN1, Ming-hui WU1(), Di ZHANG1, Dong-min HOU1, Jun-hua WANG1, Jing-wei JIANG1, Zhao-xia JIA1   

  1. 1. Capital Medical University Affixed Beijing Obstetrics and Gynecology Hospital, Beijing Maternal and Children Health Hospital, Beijing 100026, China
  • Received:2013-01-20 Revised:2013-06-18 Published:2013-08-01
  • Corresponding author: Ming-hui WU
  • About author:
    (Corresponding author: WU Ming-hui, Email: )
引用本文:

陈蔚, 武明辉, 张娣, 侯东敏, 王军华, 蒋京伟, 贾朝霞. 巨大儿的发生及其影响因素[J]. 中华妇幼临床医学杂志(电子版), 2013, 09(04): 468-472.

Wei CHEN, Ming-hui WU, Di ZHANG, Dong-min HOU, Jun-hua WANG, Jing-wei JIANG, Zhao-xia JIA. Occurrence and Influencing Factors of Macrosomia[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2013, 09(04): 468-472.

目的

探讨产妇分娩巨大儿的危险因素。

方法

自2010年1月至12月在本院产科分娩的产妇中,选取病历资料完整的7805例产妇(单胎妊娠)为研究对象。按照产妇分娩新生儿的出生体重,将其入组巨大儿组(n=593,出生体重≥4000 g)和正常体重儿组(n=7212,4000 g>出生体重≥2500 g)。采取回顾性分析法对两组产妇的相关指标,如体重指数(BMI),葡萄糖耐量试验(OGTT)结果及产妇的一般情况、孕期体重、血糖、分娩情况等进行单因素分析。对单因素分析中有统计学意义的指标,进行非条件多因素logistic回归分析(本研究遵循的程序符合本院人体试验委员会所制定的伦理学标准,得到该委员会批准,分组征得受试对象本人的知情同意,并与之签署临床研究知情同意书)。

结果

①两组产妇的分娩年龄、产前检查开始孕龄、产次、新生儿窒息率等比较,差异无统计学意义(P>0.05)。②巨大儿组产妇孕次、孕前体重与BMI,产前体重与BMI、空腹血糖值及OGTT 1 h,2 h血糖值,分娩孕龄、方式与新生儿性别、出生体重、窒息率等与正常体重儿组产妇比较,差异有统计学意义(P<0.05)。③分娩孕龄≥40孕周、产前肥胖、孕次为6次、分娩方式为剖宫产、空腹血糖≥5.1 mmol/L、分娩男胎及OGTT 2 h血糖≥8.5 mmol/L是巨大儿发生的高危因素。

结论

控制空腹及餐后2 h血糖,控制孕期体重增加,降低产前BMI,适时终止妊娠等,可降低巨大儿的发生。

Objective

To investigate the risk factors of gestational women who delivered macrosomia.

Methods

Clinical data of 7805 pregnant women(singleton pregnancy)who had antenatal care and delivered in Capital Medical University Affixed Beijing Obstetrics and Gynecology Hospital from January to December 2010 were retrospectively analyzed. According to birthweight of neonats, they were divided into macrosomia group (n=593, birthweight≥4000 g) and normal neonate weight group(n=7212, 4000 g>birthweight≥2500 g). All the indicators relevant to macrosomia were analyzed, such as body mass index(BMI), oral glucose tolerance test(OGTT), common situation, gestational weight, blood glucose and delivery situation. They were firstly analyzed by univariate analysis method. Then the meaningful indicators were analyzed by non-conditional multivariate logistic regression method.The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Capital Medical University Affixed Beijing Obstetrics and Gynecology Hospital. Informed consent was obtained from the parents of each participating neonate.

Results

①There had significance difference between two groups among ages, parities, gestational age at time to begin antenatal examination and asphyxia rate of neonates(P>0.05). ②There had significance difference between two groups among gravidities, pre-pregnancy weight, pre-pregnancy BMI, prenatal weight, prenatal BMI, gestational weight gain, fasting plasma glucose, levels of OGTT 1 h, 2 h, gestational age, modes of delivery, gestational age at delivery, and birth weight, sex of neonates(P<0.05). ③Analyzed by non-conditional multivariate logistic regression showed those high risk factors for macrosomia were gestational age≥40 weeks, BMI≥28 kg/cm2 at delivery, the number of pregnancies reaching 6, cesarean section, fasting plasma glucose≥5.1 mmol/L, male fetus and blood glucose levels of OGTT 2 h≥8.5 mmol/L.

Conclusions

To control levels of fasting plasma glucose and levels of postprandial blood glucose, keep the gestational weight in appropriate ranges, decrease the prenatal BMI and terminate pregnancy timely can reduce incidence of macrosomia.

表1 两组产妇及新生儿的一般临床资料的单因素分析结果比较[n(%)]
Table 1 Comparison of general clinical data between two groups of pregnant women and neonatals[n(%)]
组别 n 分娩年龄(岁,±s) 孕次(次) 产次(次) ?
1 2~3 4~5 6 1 ≥2
巨大儿组 593 30.1±3.4 254(42.83) 286(48.23) 44(7.42) 9(1.52) 544(91.7) 49(8.3)
正常体重儿组 7212 30.4±3.7 3613(50.10) 3057(42.39) 480(6.66) 62(0.86) 6642(92.1) 570(7.9)
χ2/t ? 1.74 13.29 0.08
P ? 0.082 0.004 0.96
组别 产前检查开始孕龄(孕周,±s) 孕前体重(kg,±s) 孕前BMI(kg/m2)
低体重 正常(理想)体重 超重 肥胖
巨大儿组 17.8±4.5 59.5±8.3 49 (8.2) 413(69.7) 108(18.2) 23(3.9)
正常体重儿组 17.5±4.3 55.1±8.0 1349(18.7) 4976(69.0) 728(10.1) 159(2.2)
χ2/t -1.20 -12.61 73.47
P 0.231 0.000 0.000
组别 产前体重(kg,±s) 产前BMI(kg/m2) 空腹血糖(mmol/L)
低体重 正常(理想)体重 超重 肥胖 <5.1 ≥5.1
巨大儿组 78.6±9.3 0(0.00) 19 (3.2) 202(34.1) 371(62.6) 490(82.6) 103(17.4)
正常体重儿组 71.9±9.1 2(0.02) 1009(14.0) 3627(50.3) 2574(35.7) 6615(91.7) 593 (8.3)
χ2/t -17.33 187.04 55.47
P 0.000 0.000 0.000
组别 OGTT 1 h血糖(mmol/L) OGTT 2 h血糖(mmol/L) 分娩方式
<10.0 ≥10.0 <8.5 ≥8.5 产钳 剖宫产 自然产
巨大儿组 519(87.5) 74(12.5) 538(90.7) 55(9.3) 10(1.7) 363(61.2) 220(37.1)
正常体重儿组 6541(90.7) 671 (9.3) 6750(93.6) 462(6.4) 159(2.2) 3253(45.1) 3801(52.7)
χ2/t 6.52 7.26 57.51
P 0.008 0.006 0.000
组别 胎膜早破 分娩孕龄(孕周) 新生儿性别
37~38 38~39 39~40 ≥40
巨大儿组 105(17.7) 488(82.3) 12(2.0) 91(15.3) 162(27.3) 328(55.3) 390(65.8) 203(34.2)
正常体重儿组 1623(22.5) 5589(77.5) 618(8.6) 2049(28.4) 2188(30.3) 2356(32.7) 3721(51.6) 3491(48.4)
χ2/t 7.20 146.34 44.15
P 0.007 0.000 0.000
组别 新生儿体重(g,±s) 新生儿窒息率
巨大儿组 4220.1±210.0 5(1.5)
正常体重儿组 3350.0±324.5 52(0.7)
χ2/t 92.24 3.50
P 0.000 0.061
表2 巨大儿发生的相关因素非条件多因素logistic回归分析结果
Table 2 Analysis of the relative factors in macrosomia with non-conditional multivariate logistic regression
1
Yue J, ed. Obstetrics and gynecology.7th ed[M].Beijing:People's Medical Publishing House,2008,123.
2
Eriksson M, Wedel H, Wallander MA, et al. The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age[J]. Prostate, 2007,67:1247-1254.
3
Harder T, Plagemann A, Harder A. Birth weight and subsequent risk of childhood primary brain tumors:A Meta-analysis[J]. Am J Epidemiol, 2008,168:366-373.
4
Hjalgrim LL, Westergaard T, Rostgaard K, et al. Birth weight as a risk factor for childhood leukemia: A Meta-analysis of 18 epidemiologic studies[J]. Am J Epidemiol, 2003,158:724-735.
5
Remes ST, Patel SP, Hartikainen AL, et al. High birth weight, asthma and atopy at the age of 16[J]. Pediatr Allergy Immunol, 2008,19:541-543.
6
China Obesity Task Guide Working Group. The Chinese adult body mass index classification recommendations[J].Chin J Prev Med,2001,35(5):394-350.
7
Lu YY, Zhang J, Lu XR, et al. Secular trends of macrosomia in southeast China, 1994-2005[J]. BMC Public Health, 2011,11:818-826.
8
Gyurkovits Z, Kálló K, Bakki J, et al. Neonatal outcome of macrosomic infants: An analysis of a two-year period[J]. Eur J Obstet Gynecol Reprod Biol, 2011,159:289-292.
9
Grissa O, Atègbo JM, Yessoufou A, et al. Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia[J]. Translat Res, 2007,150: 164-171.
10
Donma MM. Macrosomia, top of the iceberg :The charm of underlying factors[J]. Pediatr Int,2011,53:78-84.
11
Hermann GM, Dallas LM, Haskell SE, et al. Neonatal macrosomia is an independent risk factor for adult metabolic syndrome[J]. Neonatology, 2010, 98:238-244.
12
Sun WJ, Zhu SL, Yang HX, et al.Influencing factors on insulin administration in women with gestational diabetes mellitus[J/CD].Chin J Obstet Gylycol Pediatr, 2009,5(4):151-154.
13
Bhattacharya S, Campbell DM, Listion WA. Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies[J]. BMC public Health. 2007,7:168.
14
Kabali C, Werler MM. Pre-pregnant body mass index, weight gain and the risk of delivering large babies among non-diabetic mothers[J]. Int J Gynaecol Obstet,2007,97:100-104.
15
IADPSG Consensus Panel.International Association of Diabetes and Pregnancy Study Groups (IADPSG) recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J]. Diabetes Care, 2010,33: 676-682.
16
Langer O. Fetal macrosomia:Etiologic factor[J]. Clin Obstet Gynecol,2000,43:283-297.
17
Sun PP, Li HP, Zhao F.Analysis of risk factors for macrosomia in pregnant women with abnormal glucose metabolism[J]. J Pract Obstet Gynecol,2012,28:64-67.
18
Parretti E, Mecacci F, Papini M, et al. Third-trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies: Correlation with sonographic parameters of fetal growth[J]. Diabetes Care, 2001,24:1319-1323.
19
Jin R, Cheng HD.Correlation of fetal macrosomia to glucose metabolism in pregnant woman[J]. J Pract Obstet Gynecol,2006, 22:239-240.
20
Yu DM, Zhai FY, Zhao LY,et al.Incidence of fetal macrosomia and influencing factors in China in 2006[J].Chin J Child Healt Care,2008,16(1):11-13.
21
Ezegwui HU, Ikeako LC, Egbuji C. Fetal macrosomia :Obstetric outcome of 311 cases in UNTH, Enugu, Nigeria[J]. Niger J Clin Pract, 2011,14:322-326.
22
Fu Q, Fan JX.Related factor analysis of 474 cases with macrosomia[J].Chin J Woman Child Healt Res,2011,22(5):581-583.
23
Cheng YW, Nicholson JM, Nakagawa S, et al. Perenatal outcomes in low-risk term pregnancies:Do they differ by week of gestation[J].Am J Obstet Gynecol,2008,199(4):370.E1-E7.
24
Ju H, Chadha Y, Donovan T, et al. Fetal macrosomia and pregnancy outcomes[J]. Aust NZ J Obstet Gynaecol,2009,49:504-509.
25
Di Renzo GC, Rosati A, Sart RD, et al. Does fetal sex affect pregnancy outcome[J]? Gend Med,2007,4:19-30.
[1] 刘嘉嘉, 王承华, 陈绪娇, 刘瑗玲, 王善钰, 屈海花, 张莉. 经阴道子宫-输卵管实时三维超声造影中患者疼痛发生情况及其影响因素分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 959-965.
[2] 高玲, 于哲, 范然, 臧银善. 外周血细胞计数比值评估类风湿关节炎疗效的价值[J]. 中华关节外科杂志(电子版), 2023, 17(05): 642-647.
[3] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[4] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[5] 王鹏, 肖厚安, 贾赤宇. 不同因素调控巨噬细胞极化在慢性难愈性创面中的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 454-459.
[6] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[7] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[8] 黄汇, 朱信强. 131I治疗45岁以下分化型甲状腺癌的疗效及影响因素[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 627-630.
[9] 王帆, 马秋月, 刘小莉. 基于分位数回归模型的切口疝手术患者住院费用影响因素分析[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 522-529.
[10] 汪俊谷, 潘华琴, 杨雨田. HFNC治疗急性低氧性呼吸衰竭插管预后及影响因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 523-525.
[11] 顾娇娇, 邹燕, 陈奕辰, 黄师菊, 张慧玲, 林楠. 基于简易营养评价精法评估肝癌患者出院后营养状况及其影响因素[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 534-539.
[12] 杨静, 顾红叶, 赵莹莹, 孙梦霞, 查园园, 王琪. 老年血液透析患者短期死亡的影响因素及列线图预测模型的预测作用[J]. 中华肾病研究电子杂志, 2023, 12(05): 254-259.
[13] 黄岩, 刘晓巍, 杨春玲, 兰烨. 急性胰腺炎合并糖尿病患者的临床特征及血糖代谢与病情严重度的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 439-442.
[14] 刘代江, 蒋俊艳, 万晓强, 马莎英. 结直肠癌肝转移患者生存状况及预后影响因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 284-288.
[15] 杜振双, 胡清福, 林颖艺, 张月霞, 陈美丽, 李祎祺, 王振华. 社区全科医师激励机制的影响因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 876-883.
阅读次数
全文


摘要